Assessment of circulating apoE4 levels from dried blood spot samples in a large survey setting
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · 2024-01 · 16 (1)
DOI: 10.1002/dad2.12555 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, online erschienen am 22.02.2024. Verfasst von Nis Borbye-Lorenzen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Congenital Disorders Center for Neonatal Screening, Statens Serum Institut Copenhagen Denmark. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, National Institute on Aging, Max-Planck-Gesellschaft.
Abstract (Originalsprache)
INTRODUCTION The apolipoprotein E ( APOE ) ε4 allele is associated with high risk for Alzheimer's disease. It is unclear whether individual levels of the circulating apoE4 protein in ε4 carriers confer additional risk. Measuring apoE4 protein levels from dried blood spots (DBS) has the potential to provide information on genetic status as well as circulating levels and to include these measures in large survey settings. METHODS We developed a multiplex immunoassay to detect apoE4 protein levels in DBS from 15,974 participants, aged 50+ from Wave 6 of the Survey of Health, Ageing and Retirement in Europe (SHARE). RESULTS The apoE4 protein signal was presented in two separable distributions. One distribution corresponded to carriers of at least one copy of the ε4 allele. Fieldwork cofounders affected protein levels but did not explain individual differences. DISCUSSION Future research should investigate how genotype and apoE4 level interact with lifestyle and other variables to impact cognitive aging.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Congenital Disorders Center for Neonatal Screening, Statens Serum Institut Copenhagen Denmark.
- Institute of Psychology University of the Bundeswehr München Neubiberg Germany.
- Max Planck Institute for Social Law and Social Policy Munich Germany.
- The Munich Research Institute for the Economics of Aging and SHARE Analyses (MEA) Munich Germany.
- National Bureau of Economic Research Cambridge Massachusetts USA.
- Survey of Health, Ageing and Retirement in Europe (SHARE Biomarker Project) Munich Germany.
ORCID-Profile: Nis Borbye-Lorenzen, Yacila I Deza-Lougovski, Marie Bækvad-Hansen, Kristin Skogstrand, Anna Rieckmann, Axel Börsch-Supan, Martina Börsch-Supan
Förderung
- NIA NIH HHS
- National Institute on Aging
- Max-Planck-Gesellschaft
- European Commission
- Horizon 2020
Zitieren
APA
Borbye-Lorenzen, N., Deza-Lougovski, Y. I., Holmgaard, S., Weiss, L. M., Bækvad-Hansen, M., Skogstrand, K., Rieckmann, A., Börsch-Supan, A., & Börsch-Supan, M. (2024). Assessment of circulating apoE4 levels from dried blood spot samples in a large survey setting. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 16(1). https://doi.org/10.1002/dad2.12555
Vancouver
Borbye-Lorenzen N, Deza-Lougovski YI, Holmgaard S, Weiss LM, Bækvad-Hansen M, Skogstrand K, et al. Assessment of circulating apoE4 levels from dried blood spot samples in a large survey setting. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2024;16(1). doi:10.1002/dad2.12555
BibTeX
@article{BorbyeLorenzen2024,
author = {Borbye-Lorenzen, Nis and Deza-Lougovski, Yacila I and Holmgaard, Solveig and Weiss, Luzia M and Bækvad-Hansen, Marie and Skogstrand, Kristin and Rieckmann, Anna and Börsch-Supan, Axel and Börsch-Supan, Martina},
title = {Assessment of circulating apoE4 levels from dried blood spot samples in a large survey setting},
journal = {Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring},
year = {2024},
volume = {16},
number = {1},
doi = {10.1002/dad2.12555}
}
EUVIMED